This site is intended for
U.S. healthcare professionals
Enrollment and Prescription Form Available Soon
The Enrollment and Prescription Form is not yet available.
Please check back to download the latest form.
Return to previous pagePatients With PAH Often Face a Delayed Diagnosis and Inadequate Treatment1
The 2022 ESC/ERS Guidelines recommend combination therapy for treatment of PAH at diagnosis and follow-up depending on risk status4†
Science Liaison (MSL)Contact your MSL
*
REVEAL was a US-based, observational registry involving 55 academic- and community-based treatment centers. 3515 patients enrolled between March 2006 and December 2009. REVEAL was funded and sponsored by Actelion Pharmaceuticals US, Inc.1,5
†
In patients with idiopathic PAH, heritable PAH, PAH-CTD, or drug-associated PAH and without cardiopulmonary comorbidities.4
ERS=European Respiratory Society; ESC=European Society of Cardiology; PAH=pulmonary arterial hypertension; PAH-CTD=PAH associated with connective tissue disease; REVEAL=Registry to EValuate EArly and Long-term PAH Disease Management.
References: 1. Badesch DB, Raskob GE, Elliott CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest. 2010;137(2):376-387. 2. Didden EM, Lee E, Wyckmans J, et al. Time to diagnosis of pulmonary hypertension and diagnostic burden: a retrospective analysis of nationwide US healthcare data. Pulm Circ. 2023;13(1):e12188. doi:10.1002/pul2.12188 3. Brown LM, Chen H, Halpern S, et al. Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. Chest. 2011;140(1):19-26. 4. Humbert M, Kovacs G, Hoeper MM, et al; ESC/ERS Scientific Document Group. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J. 2022;43(38):3618-3731. 5. McGoon MD, Miller DP. REVEAL: a contemporary US pulmonary arterial hypertension registry. Eur Respir Rev. 2012;21(123):8-18.
